Dr. S.0 MIKAYE / LinkedIn
Jun 8, 2026, 03:03
Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
Samwel Mikaye, Medical Doctor at MSK, shared a post on LinkedIn:
“D-Dimer
Definition
D-dimer is a fibrin degradation product formed when a blood clot is broken down by fibrinolysis.
It reflects recent or ongoing clot formation and breakdown.
What it indicates
- Active thrombosis plus fibrinolysis
- Not specific for one disease (very sensitive, low specificity)
When D-dimer is raised
1. Thrombotic conditions
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
- Disseminated intravascular coagulation (DIC)
2. Other causes (non-specific)
- Infection / sepsis
- Trauma or surgery
- Pregnancy
- Malignancy
- Liver disease
- Inflammation
Clinical use (VERY IMPORTANT in OSCE)
Rule-out test (NOT rule-in)
- Low D-dimer – helps exclude DVT/PE in low-risk patients
- High D-dimer – needs further imaging (not diagnostic alone)
D-dimer in DVT/PE pathway
- First assess clinical probability (Wells score)
- If low risk plus negative D-dimer – DVT/PE excluded
- If high risk or positive D-dimer – do imaging (Doppler / CTPA)
Limitations
- Very non-specific
- Can be elevated in many conditions
- Levels increase with age (elderly often have false positives)
‘D-dimer – D for Detection of clot breakdown’
Good to rule OUT, not rule IN thrombosis
D-dimer is a fibrin breakdown marker used to exclude DVT/PE in low-risk patients, but it is non-specific.”

Stay updated with Hemostasis Today.
-
Nov 10, 2026, 16:28Can the VWF to ADAMTS-13 Ratio Predict Mortality in Sepsis-Induced Coagulopathy? – RPTH Journal
-
Nov 10, 2026, 16:28Ruth Willems: PhD Defence at Maastricht University on Thrombosis and Bleeding in HPB Disease
-
Nov 10, 2026, 16:09Edward Lee Carter: Factor XIa Inhibition Enters Clinical Practice
-
Nov 10, 2026, 16:08Edward C.C. Wong: Deriving Ferritin Cutoffs for Iron Deficiency Using RBC Parameters
-
Nov 10, 2026, 16:07Milad Abdalla: Decoding Hemoglobin Electrophoresis – A Practical Diagnostic Reference
-
Nov 10, 2026, 15:13Wolfgang Miesbach: Nonviral Gene Therapy for Haemophilia A Using Lipid Nanoparticles
-
Nov 10, 2026, 15:06Dahra Teles: First Speaking Experience at HEMO 2026 on First-Line Multiple Myeloma Treatment
-
Nov 10, 2026, 14:55Yazan Abou-Ismail: First FDA-Approved Factor XIa Inhibitor for Stroke Prevention
-
Nov 10, 2026, 14:49Ifeanyichukwu Ifechidere: The Role of Coagulation in Anaesthesia and Surgery